The prevalence of atrial fibrillation (AF) in active astronauts is ≈5%, similar to the general population but at a younger age. Risk factors for AF include left atrial enlargement, increased number of premature atrial complexes, and certain parameters on signalaveraged electrocardiography, such as P-wave duration, root mean square voltage for the terminal 20 ms of the signal-averaged P wave, and P-wave amplitude. We aimed to evaluate changes in atrial structure, supraventricular beats, and atrial electrophysiology to determine whether spaceflight could increase the risk of AF.
A trial fibrillation (AF) is the most common arrhythmia in the United States, and its prevalence increases with age. The prevalence in the general population is ≈6% in those >60 years of age. For astronauts, 17 cases of atrial arrhythmias have been identified among 317 active and retired astronauts since the late 1950s. Since 2001, 5 of ≈100 active astronauts underwent radiofrequency ablation for atrial arrhythmias (most of which were AF), which calculates to a prevalence of 5%. Although the prevalence is similar to that of the general population, the presentation in astronauts is much younger, with all affected active astronauts being between 41 and 45 years of age.
AF in astronauts is a particular concern, especially with prolonged spaceflight because of limited access to care and the risk of impaired exercise performance, poorly controlled ventricular response, and even emboli. Several factors may contribute to increased risk of AF in astronauts. One such factor is increased atrial size; for example, left atrial (LA) enlargement is associated with AF in athletes and in the elderly. [1] [2] [3] [4] [5] [6] During prolonged spaceflight, body fluid is redistributed toward the head because of microgravity; ≈10% of the volume in the
WHAT IS KNOWN?
• The prevalence of atrial fibrillation in astronauts is ≈5%.
• The prevalence is similar to that of the general population but at a younger age of presentation.
• Risk factors for atrial fibrillation include left atrial enlargement, increased number of premature atrial complexes, and certain parameters on signal-averaged electrocardiography, such as P-wave duration, root mean square voltage for the terminal 20 ms of the signal-averaged P wave, and P-wave amplitude.
WHAT THE STUDY ADDS?
• Six months of spaceflight are sufficient to cause transient changes in left atrial structure and changes in certain aspects of atrial electrophysiology. • However, there was no clear change in other potential risk factors of atrial electrophysiology, such as filtered P-wave duration or the number of premature atrial complexes.
• As such, more prolonged monitoring may be necessary to determine the clinical significance of these findings.
lower limbs decreases compared with preflight. 7 This fluid shift causes the heart to be acutely distended (and remain distended compared with the upright posture chronically), potentially placing the astronauts at risk for AF. Endurance athletes are noted to be at increased risk of AF, and the risk correlates with the amount of time spent training. [3] [4] [5] [6] Because astronauts undertake intensive exercise training to counter spaceflight-induced decrease in aerobic capacity and to prevent loss of bone and muscle, they may inadvertently be at a higher risk for AF perhaps because of the combined effect of increased atrial volume from spaceflight and high heart rate during training. 8 It should be noted, however, that their fitness levels are modest (average of this population, 41 mL/kg per minute) and do not increase in-flight. 9 In addition to atrial size, increased number of premature atrial complexes (PACs) or supraventricular beats identifies patients at risk for AF in endurance athletes 5 and in those with acute stroke. 10 A higher resolution assessment of atrial electrophysiology via signal-averaged ECG (SAECG) has shown that certain parameters predict risk of AF, such as prolonged P-wave durations, lower root mean square voltages (RMSs), and changes in P-wave amplitude. 5, [11] [12] [13] [14] [15] [16] Thus far, there is no evidence of spaceflight-induced increase in arrhythmia burden or changes in electrophysiological substrate that would increase the risk of life-threatening arrhythmias in space. Therefore, we aimed to evaluate atrial structure, supraventricular beats in the form of PACs, and changes in atrial electrophysiology (P-wave signal averaging, including duration, late potentials, and amplitudes) to determine whether spaceflight and the accompanying training would increase the risk of AF. We hypothesized that 6 months of spaceflight would alter atrial size and atrial electrical function, thereby increasing the risk of AF.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure on direct request. The Integrated Cardiovascular Experiment is a partnership among academia and the National Aeronautics and Space Administration (NASA), extending from Increment 20 to Increment 34 on the International Space Station from 2009 to 2013. We studied 13 astronauts (9 men and 4 women) who spent ≈6 months in space and volunteered to be part of the study and obtained preflight, in-flight, and postflight measurements, including at least 2 repetitions on the ground for baseline studies to determine typical error of measurement. The study was approved by an institutional review committee, and the subjects gave informed consent. The median age of the study population was 49 years, and all crew members met NASA medical standards to fly in space. The study subjects did not have any significant medical history and were not on any medication that could affect adrenergic tone. The following assessments were performed on all subjects: cardiac magnetic resonance imaging with gadolinium contrast preflight, early postflight (generally within the first 5 days), and late postflight (3 to 8 weeks after landing to monitor recovery [N=11]); highresolution Holter monitoring was also performed for multiple 48-hour time periods preflight, in-flight, and on landing day.
CARDIAC MAGNETIC RESONANCE IMAGING
Cardiac magnetic resonance imaging was performed in the supine position using a 3T Philips scanner for the first 6 astronauts and a Siemens 3T scanner for the last 7. Long-axis images in 2-, 3-, and 4-chamber views were acquired using steady-state free precession sequences with retrospective ECG triggering. Left and right atrial maximal volumes were defined as the largest volume just before the start of diastolic filling of the ventricles. LA volumes were obtained using long-axis images in the 2-, 3-, and 4-chamber views. For RA volumes, the area of the RA in the 4-chamber view was measured, as well as longitudinal (RA long) and transversal diameter (RA trans) (Figure 1) . Atrioventricular plane displacement was defined in long-axis images as described by Carlsson et al 17 and measured using a semiautomatic tracking method followed by manual correction. 18 All measurements were done using the software Segment, version 2.0 R4677.
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P-WAVE SAECG
High-resolution Holter monitoring for multiple 48-hour time periods was obtained using a Mortara XScribe system (Mortara Instruments) at a 1-kHz sample rate. P-wave SAECG analysis was performed on a 10-minute segment obtained during rest. The Holter monitoring was performed on flight days 14, 30, 75, and 135, as well as 15 days before landing and on landing day. The digital ECG files were analyzed in a blinded fashion with custom software designed using MATLAB (Mathworks, Natick, MA). An experienced electrophysiologist blindly analyzed the Holter recordings for quantification of all arrhythmias, including AF, supraventricular ectopy, and ventricular ectopy. Because SAECG analysis is typically performed using orthogonal-lead recordings, the 12-lead ECG was first converted to a Frank (XYZ) lead equivalent using the inverse Dower transform. 20 Beats were first detected using the QRS complexes and then signal averaged. The P waves were then redetected by cross-correlation with initial signal-averaged P-wave template. Beats where the average voltage values exceeded 2 SDs from the initial averaged P wave were excluded from further analysis. The remaining beats with timings adjusted by cross-correlation were used to make the final signal-averaged P waves for each of the 3 XYZ leads. The averaged P waves were then filtered with a bidirectional 40 Hz high-pass filter, and then the magnitude of the filtered XYZ waveform was comput-ed. The P-wave onset and offset were determined as the points where the P wave reached the noise level. The filtered P-wave duration (in milliseconds), the RMS for the terminal 20 ms (RMS20) of the signal-averaged P wave (in microvolts), and the unfiltered P-wave amplitude of the 12-lead ECG were calculated ( Figure 2 ).
Statistical Analysis
Data were expressed as mean, with SD unless otherwise noted. A paired t test was used to assess the differences in the frequency of PACs between preflight, during flight, and landing. For continuous variables, linear mixed-effects models for repeated measures were used to compare the measurements collected before, during, and after spaceflight. The study participant was modeled as random effect. All available data were included in the models. Pairwise comparisons were made using least-squares means and contrasts from the mixedeffects models. A 2-sided P value <0.05 was considered statistically significant. Analyses were conducted using IBM SPSS statistics, version 22, and SAS software, version 9.4 (SAS Institute, Cary, NC).
RESULTS
Atrial Size
LA volume transiently increased after 6 months in space (δmean±SD, 12±18 mL; P=0.03) with a return to baseline after several weeks. Right atrial size remained unchanged with RA area δ1±3 mm2 (P=0.34), RA longitudinal diameter 1±3 mm (P=0.66), and RA transversal diameter 2±5 mm (P=0.21; Figure 3 
Premature Atrial Contractions
When compared with baseline data of supraventricular beats before flight, no changes were noted over time on flight days 14, 30, 75, 135, 15 days before landing, and on landing day (first 24 hours on earth; Table 1) . One astronaut had a large increase in supraventricular ectopic beats, but none developed AF (Figure 4) .
SAECG of the P Wave
There were no differences in filtered or nonfiltered P-wave duration over time ( Figure 5 ). However, there was a decreased RMS20 compared with preflight on all fight days except landing day ( Figure 6 ).
No changes in P-wave amplitude were seen in leads II or V 1 except a decrease on landing day for V 1 (Figure 7) . No changes in P-wave amplitude were seen in leads III and aVL. A decrease in P-wave amplitude was noted on flight day 30 for lead I, 15 days before landing for lead aVr, on landing day for lead aVF, and on all flight days except flight day 14 for lead V 2 . A decrease in P-wave amplitude was noted for all flight days and landing day for leads V 3 through V 5 ( Table 2 ). The astronaut with a marked increase in PACs had no apparent changes in SAECG parameters.
DISCUSSION
The key findings from the present study include the following: (1) 6 months of space travel led to a transient increase in LA but not right atrial size. (2) There was no significant change in filtered P-wave duration; however, changes in P-wave electrophysiology were noted for RMS20 and P-wave amplitudes in some leads. (3) There was no significant increase in supraventricular arrhythmias.
Effects of Spaceflight on Atrial Structure
On exposure to microgravity, central fluid shifts cause the heart to acutely enlarge, leading to atria that are more distended than they are in the upright position on earth. 21, 22 Although there are reports of AF in astronauts on the ground, no prior reports have assessed changes in LA size in astronauts via cardiac magnetic resonance imaging. Given the sustained central volume load of spaceflight, and the relatively younger presentation of astronauts with AF compared with the general population, we wondered whether this microgravity physiology could increase the risk for astronauts developing AF during long-duration spaceflight.
LA enlargement, whether as a function of aging 1,2 or as a dose-dependent 5 physiological adaptation to exercise in long-term endurance athletes, 23, 24 is an independent risk factor for lone AF. [3] [4] [5] For example, a cross-sectional study on nonelite runners found that athletes who have the highest lifetime training hours (>4500 hours) had the highest risk of AF, 5 although a recent longitudinal study in middle-aged men and women did not find any changes in atrial electrophysiology, despite a dose of exercise sufficient to cause physiological hypertrophy. 25 Moreover, similar to endurance athletes, astronauts also partake in intensive exercise training to counter spaceflight-induced decreases in aerobic capacity, as well as bone and muscle atrophy. However, it is important to note that on average, astronauts are not especially fit. Their average maximal oxygen consumption (VO 2 max), a measurement indicative of one's cardiorespiratory fit- ness, in the International Space Station era is only ≈41 mL/kg per minute, 9 (including many of the astronauts in this study), which is similar to what we have reported previously in Shuttle era astronauts. 26 Their endurance and strength training on orbit, although time consuming, is barely enough to preserve their fitness. 9 In contrast, the central fluid shift that occurs in space is universal, and virtually all astronauts experience hemodynamic conditions that are closer to the supine than upright positions. Therefore, we suspect that the hemodynamics of microgravity, rather than any extraordinary exercise training, is the cause of any changes in atrial structure or function, although perhaps the effect of increased heart rate and thereby increasing atrial damlike effects and distension 8 could be synergistic. Further supporting the notion that atrial distension is an adaptation to the microgravity environment is the finding that LA size returned to normal after a few weeks back on earth. The early postflight studies were done after gravitational gradients had already been restored to normal, after removal of the central fluid shift of space arguing that the measured increase in size was a response to the previous spaceflight exposure, similar to the cardiac remodeling after exercise training. 27, 28 The late follow-up data show that like with athletes who decondition, 29 or patients who have repair of mitral regurgitation, 30 once the hemodynamic stimulus is removed, the heart will quickly decrease in size resulting in resolution of physiological hypertrophy.
Effects of Spaceflight on Atrial Electrical Function
Late potentials represent depolarization of slowly conducting myocardium; atrial late potentials are thought to exist when P-wave duration is prolonged and RMS20 is decreased. 31 Atrial conduction disturbances can be reflected by the conduction delay during sinus rhythm, observed as the prolongation in the P-wave duration. Therefore, prolonged P-wave duration has been used as an index for progression of conduction disturbance to AF, and it has been associated with AF in several different populations. For example, P-wave duration was related to the risk of AF in individuals perform- Before flight was used as baseline, and P value was calculated using paired t test. ing high lifetime doses of exercise training in a dosedependent fashion (longer cumulative hours of training were associated with longer P-wave duration).
5 P-wave duration was also significantly longer in middle-aged patients with a history of paroxysmal AF compared with an aged and sex-matched control group. 11 Finally, in patients undergoing cardioversion, the incidence of recurrent AF was higher in patients with longer P-wave duration. 12, 16, 32 In the present study, filtered P-wave duration did not increase after prolonged spaceflight in astronauts counterbalancing the apparent risk from increased LA size.
Decreased RMS, another measure of atrial late potentials, has also been associated with increased risk of AF in several studies. For example, in the same studies described above, RMS10 and RMS20 were significantly lower in patients with paroxysmal AF compared with an age-and sex-matched control group, 11 as well as in patients who had recurrent AF after cardioversion. 16, 32 In our study, we found that RMS20 was decreased compared with preflight on all fight days except landing day, when prominent sympathetic activation 33 may have countered changes in atrial electrophysiology.
Atrial conduction disturbances may also result in various changes in the atrial activation vector, which may lead to P-wave amplitude variations in several leads. Changes in P-wave amplitude have been associated with AF in a few studies; however, the findings have been inconsistent. In the same prospective cohort study of patients who underwent cardioversion noted above, the incidence of immediate recurrence of AF was higher in patients with lower P-wave amplitude for leads II and V 1 . 12 Similarly, in patients with paroxysmal AF who underwent radiofrequency catheter ablation, low P-wave amplitude (<0.1 mV) in lead I independently predicted clinical recurrence. 13 However, findings from a case-control study showed that the P-wave amplitude in leads II and V 1 was actually higher in patients with new-onset AF compared with control emphasizing the unpredictable nature of this finding. 15 In our study, P-wave amplitude did not change in leads II and V 1 , where the P wave is the most prominent, except for V 1 on the landing day. However, P-wave amplitude changes were noted for all flight days and landing day for leads V 3 through V 5 , although the clinical implication of such a finding is unclear because it is difficult to standardize lead position past V 2 . Therefore, although we found statistically significant differences compared with preflight in the precordial leads, we suspect that this observation may be because of changes in heart position and shape because the heart becomes more globular in space.
In addition to the P-SAECG parameters, the number of PACs can predict risk of AF in different populations. For example, an increased number of PACs was related to AF in endurance athletes. 5 Moreover, in older patients with acute stroke, the number of PACs on a routine 24-hour Holter ECG was a strong, dosedependent, independent predictor of subclinical AF. FD) 14, 30, 75, 135, 15 d before landing (R-15) , and on landing day (R0) in 13 subjects. Error bar denotes mean±SD. *Statistically significant difference from preflight value.
The number of PACs did not increase during spaceflight in our study, although there was 1 astronaut (1 of 13 or 8%) who did have a prominent increase in PACs during spaceflight.
In summary, 6 months in space caused a transient increase in LA (but not RA) size and a decrease in the RMS20 but no meaningful changes in P-wave duration or amplitude and no consistent increase in atrial ectopy. Moreover, there was no change in atrial mechanical function. Together, these data are not dispositive but do raise the possibility that long-duration (6 months) spaceflight, perhaps especially in susceptible individuals, could increase the risk of AF.
Study Limitations
Because no astronauts actually developed AF in our study, we cannot say with confidence that spaceflight increases the risk for AF. Although the duration of exposure to microgravity was long compared with previous Space Shuttle missions, it still only lasted 6 months. Longer duration follow-ups of these astronauts, including those of longer length, after recurrent missions, and surveillance over the full career (both active and retired) of these individuals will be important to help answer that question. Because an exploration class mission to Mars is projected to last 2 to 3 years, similar study of longer duration missions will be essential to understand the risk of AF in these middleaged men and women.
A few other limitations warrant discussion in our study. Changes in atrial dimensions were assessed in long-axis images because short-axis images of the atria had not been acquired. However, for the LA, volume was calculated from delineations in 3 imaging planes, allowing for 3-dimensional measurements. For the right atrium, only the 4-chamber view was available, and, therefore, only 2-dimensional measurements were made. Future imaging of astronauts should include short-axis images covering the entire atria to enable better measurements of adaptation to spaceflight. P-wave SAECG derived from 12-lead ECG rather than orthogonal-lead ECG was a nonstandard approach but was a necessary logistical compromise. Therefore, the values obtained in this study may not be comparable with published results from other studies. Sex differences may also contribute to changes in atrial size and atrial electrophysiology. 34 Our study did not separate women and men for data analysis. Furthermore, the small sample size of 13 astronauts may have limited our ability to detect changes in filtered P-wave duration and the number of increased PACs.
Conclusions
In conclusion, 6 months of spaceflight are sufficient to cause transient changes in LA structure, as well as changes in certain aspects of atrial electrophysiology that may increase risk of AF. However, there was no clear change in other potential risk factors of atrial electrophysiology, such as filtered P-wave duration or the number of PACs. More prolonged monitoring (such as with implantable loop recorders) may be required to better identify and quantify actual incidences of AF in astronauts, to determine the clinical importance of these findings.
